
Century Therapeutics, Inc.
IPSCHealthcare|Biotechnology|US
$1.68
+0.17 (+11.26%)
DCF Value
$2.59
Tangible Book / Share
$0.96
Cash / Share
$0.58
Ownership Breakdown
55.9%
Float
181.1M
Shares Outstanding
101.3M
Float Shares
Major Holders (37)
Combined: 228.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | IA, PN | 9.90% | 17,944,649 | Jan 16, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 17,944,649 | Jan 16, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 17,944,649 | Jan 16, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 17,944,649 | Jan 16, 2026 | 13D/G |
| Chen Yu | Individual | 9.90% | 17,754,430 | Jan 15, 2026 | 13D/G |
| Deep Track Capital, LP | IA, OO | 7.34% | 13,486,400 | Jan 15, 2026 | 13D/G |
| David Kroin | HC, IN | 7.34% | 13,486,400 | Jan 15, 2026 | 13D/G |
| Roderick Wong | HC, IN | 7.10% | 13,043,478 | May 15, 2026 | 13D/G |
| RTW Investments, LP | IA, PN | 7.10% | 13,043,478 | May 15, 2026 | 13D/G |
| Venrock Healthcare Capital Partners III, L.P. | Partnership | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| VHCP Co-Investment Holdings III, LLC | Other | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Venrock Healthcare Capital Partners EG, L.P. | Partnership | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| VHCP Management III, LLC | Other | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| VHCP Management EG, LLC | Other | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Nimish Shah | Individual | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Bong Y. Koh | Individual | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Commodore Capital LP | IA, PN | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Michael Kramarz | HC, IN | 7.10% | 13,043,478 | Jan 16, 2026 | 13D/G |
| Koh, Bong | Individual | 6.40% | 5,389,259 | Nov 14, 2024 | 13D/G |
| Shah, Nimish | Individual | 6.40% | 5,389,259 | Nov 14, 2024 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 5.78% | 10,609,008 | Jan 15, 2026 | 13D/G |
| TCG Crossover GP II, LLC | Other | 4.90% | 8,877,215 | Jan 15, 2026 | 13D/G |
| TCG Crossover Fund II, L.P. | Partnership | 4.90% | 8,877,215 | Jan 15, 2026 | 13D/G |
| TCG Crossover GP III, LLC | Other | 4.90% | 8,877,215 | Jan 15, 2026 | 13D/G |
| TCG Crossover Fund III, L.P. | Partnership | 4.90% | 8,877,215 | Jan 15, 2026 | 13D/G |
| Bong Y Koh | Individual | 4.70% | 3,957,186 | Feb 14, 2025 | 13D/G |
| Bain Capital Life Sciences Opportunities III, LP | Partnership | 4.10% | 3,538,609 | Nov 14, 2025 | 13D/G |
| Eli Casdin | HC, IN | 3.70% | 3,212,316 | May 15, 2025 | 13D/G |
| Casdin Capital, LLC | Investment adviser | 3.70% | 3,212,316 | May 15, 2025 | 13D/G |
| Point72 Asset Management, L.P. | Partnership | 3.30% | 5,964,678 | May 15, 2026 | 13D/G |
| Steven A. Cohen | Individual | 3.30% | 5,964,678 | May 15, 2026 | 13D/G |
| Point72 Capital Advisors, Inc. | Corporation | 3.30% | 5,964,678 | May 15, 2026 | 13D/G |
| FMR LLC | Holding company | 2.98% | 2,521,511 | Nov 12, 2024 | 13D/G |
| Abigail P. Johnson | Individual | 2.98% | 2,521,511 | Nov 12, 2024 | 13D/G |
| Deep Track Special Opportunities Fund, LP. | Partnership | 1.57% | 2,877,392 | Jan 15, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 3,073,000 acquired · 211,783 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carr Douglas | SVP Finance & Operations | Nov 3, 2026 | SELL | 266 | $1.52 | $404.05 | Form 4 |
| Russotti Gregory | See Remarks | Sep 14, 2026 | SELL | 2,587 | $1.93 | $5.0K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Sep 14, 2026 | SELL | 1,658 | $1.93 | $3.2K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Sep 11, 2026 | TAX W/H | 13,850 | $1.94 | $26.9K | Form 4 |
| Truitt Joseph | director | Sep 9, 2026 | AWARD | 148,000 | $2.03 | $300.4K | Form 4 |
| Truitt Joseph | Sep 9, 2026 | OTHER | 0 | — | — | Form 4 | |
| Pfeiffenberger Brent | director, officer: President and CEO | Sep 4, 2026 | TAX W/H | 463 | $2.11 | $976.93 | Form 4 |
| Russotti Gregory | See Remarks | Sep 8, 2026 | SELL | 534 | $2.05 | $1.1K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Sep 8, 2026 | SELL | 254 | $2.05 | $520.70 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Aug 14, 2026 | TAX W/H | 31,172 | $1.92 | $59.9K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Aug 3, 2026 | SELL | 275 | $1.98 | $543.68 | Form 4 |
| Russotti Gregory | See Remarks | Jun 12, 2026 | SELL | 2,584 | $2.23 | $5.8K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Jun 12, 2026 | SELL | 1,654 | $2.23 | $3.7K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Jun 11, 2026 | TAX W/H | 13,849 | $2.24 | $31.0K | Form 4 |
| Cowan Chad | Chief Scientific Officer | Jun 11, 2026 | TAX W/H | 358 | $2.24 | $801.92 | Form 4 |
| Riva Alessandro | director | Jun 11, 2026 | AWARD | 74,000 | $2.24 | $165.8K | Form 4 |
| Quimi Daphne | director | Jun 11, 2026 | AWARD | 74,000 | $2.24 | $165.8K | Form 4 |
| Murphy Martin Patrick | director | Jun 11, 2026 | AWARD | 74,000 | $2.24 | $165.8K | Form 4 |
| Lee Han Myung | director | Jun 11, 2026 | AWARD | 74,000 | $2.24 | $165.8K | Form 4 |
| Blackwell Kimberly | director | Jun 11, 2026 | AWARD | 74,000 | $2.24 | $165.8K | Form 4 |
| Russotti Gregory | See Remarks | Jun 8, 2026 | SELL | 524 | $2.11 | $1.1K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Jun 8, 2026 | SELL | 249 | $2.11 | $525.64 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Jun 5, 2026 | TAX W/H | 463 | $2.13 | $986.19 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | May 15, 2026 | TAX W/H | 31,172 | $2.34 | $72.9K | Form 4 |
| Carr Douglas | SVP Finance & Operations | May 4, 2026 | SELL | 264 | $2.34 | $618.02 | Form 4 |
| Murphy Martin Patrick | director | Dec 9, 2025 | AWARD | 88,000 | $0.59 | $52.1K | Form 4 |
| Murphy Martin Patrick | Dec 9, 2025 | OTHER | 0 | — | — | Form 4 | |
| Cowan Chad | Chief Scientific Officer | Apr 1, 2026 | TAX W/H | 1,365 | $2.19 | $3.0K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Mar 12, 2026 | SELL | 7,043 | $2.55 | $18.0K | Form 4 |
| Russotti Gregory | See Remarks | Mar 12, 2026 | SELL | 10,076 | $2.55 | $25.7K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Mar 11, 2026 | TAX W/H | 55,397 | $2.73 | $151.2K | Form 4 |
| Cowan Chad | Chief Scientific Officer | Mar 11, 2026 | TAX W/H | 1,431 | $2.73 | $3.9K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Mar 9, 2026 | SELL | 247 | $2.54 | $626.39 | Form 4 |
| Russotti Gregory | See Remarks | Mar 9, 2026 | SELL | 479 | $2.54 | $1.2K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Mar 6, 2026 | TAX W/H | 463 | $2.56 | $1.2K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Feb 13, 2026 | TAX W/H | 31,172 | $1.75 | $54.6K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Feb 3, 2026 | SELL | 323 | $1.82 | $588.51 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Feb 2, 2026 | AWARD | 475,000 | — | — | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Feb 2, 2026 | AWARD | 945,000 | $1.84 | $1.7M | Form 4 |
| Russotti Gregory | See Remarks | Feb 2, 2026 | AWARD | 135,000 | — | — | Form 4 |
| Russotti Gregory | See Remarks | Feb 2, 2026 | AWARD | 265,000 | $1.84 | $487.6K | Form 4 |
| Cowan Chad | Chief Scientific Officer | Feb 2, 2026 | AWARD | 135,000 | — | — | Form 4 |
| Cowan Chad | Chief Scientific Officer | Feb 2, 2026 | AWARD | 265,000 | $1.84 | $487.6K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Feb 2, 2026 | AWARD | 110,000 | — | — | Form 4 |
| Carr Douglas | SVP Finance & Operations | Feb 2, 2026 | AWARD | 225,000 | $1.84 | $414.0K | Form 4 |
| Cowan Chad | Chief Scientific Officer | Jan 2, 2026 | TAX W/H | 1,611 | $0.99 | $1.6K | Form 4 |
| Cowan Chad | Chief Scientific Officer | Dec 22, 2025 | BUY | 58,060 | $0.85 | $49.3K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Dec 12, 2025 | BUY | 52,000 | $0.58 | $30.4K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Dec 10, 2025 | TAX W/H | 463 | $0.53 | $243.54 | Form 4 |
| Lee Han Myung | director | Dec 9, 2025 | AWARD | 88,000 | $0.59 | $52.1K | Form 4 |
| Lee Han Myung | Dec 9, 2025 | OTHER | 0 | — | — | Form 4 | |
| Carr Douglas | SVP Finance & Operations | Dec 8, 2025 | SELL | 257 | $0.53 | $136.72 | Form 4 |
| Russotti Gregory | See Remarks | Dec 8, 2025 | SELL | 526 | $0.53 | $279.83 | Form 4 |
| Cowan Chad | Chief Scientific Officer | Nov 20, 2025 | SELL | 5,462 | $0.50 | $2.7K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Nov 19, 2025 | BUY | 35,000 | $0.50 | $17.3K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Nov 17, 2025 | SELL | 32,456 | $0.45 | $14.7K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Nov 3, 2025 | SELL | 292 | $0.59 | $171.11 | Form 4 |
| Cowan Chad | Chief Scientific Officer | Sep 18, 2025 | AWARD | 762,543 | — | — | Form 4 |
| Carr Douglas | SVP Finance & Operations | Sep 8, 2025 | SELL | 263 | $0.50 | $131.50 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Sep 8, 2025 | SELL | 488 | $0.50 | $244.00 | Form 4 |
| Russotti Gregory | See Remarks | Sep 8, 2025 | SELL | 539 | $0.50 | $269.50 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Aug 14, 2025 | AWARD | 1,587,614 | — | — | Form 4 |
| Carr Douglas | SVP Finance & Operations | Aug 4, 2025 | SELL | 296 | $0.53 | $158.06 | Form 4 |
| Blackwell Kimberly | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| JIMENEZ JOSEPH | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| Riva Alessandro | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| Carlo Rizzuto | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| Quimi Daphne | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| BUTITTA CYNTHIA M | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| Walbert Timothy P | director | Jun 12, 2025 | AWARD | 44,000 | $0.60 | $26.4K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Jun 9, 2025 | SELL | 4,904 | $0.62 | $3.1K | Form 4 |
| Farid Adrienne | Chief Operations Officer | Jun 9, 2025 | SELL | 552 | $0.62 | $343.34 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Jun 9, 2025 | SELL | 475 | $0.62 | $295.45 | Form 4 |
| Russotti Gregory | See Remarks | Jun 9, 2025 | SELL | 526 | $0.62 | $327.17 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | May 16, 2025 | SELL | 29,552 | $0.55 | $16.1K | Form 4 |
| Farid Adrienne | Chief Operations Officer | May 5, 2025 | SELL | 1,024 | $0.55 | $563.20 | Form 4 |
| Carr Douglas | SVP Finance & Operations | May 5, 2025 | SELL | 295 | $0.55 | $162.25 | Form 4 |
| Conn Morgan | Chief Finanical Officer | Mar 11, 2025 | AWARD | 19,500 | — | — | Form 4 |
| Conn Morgan | Chief Finanical Officer | Mar 11, 2025 | AWARD | 19,500 | $0.60 | $11.7K | Form 4 |
| Cowan Chad | Chief Scientific Officer | Mar 11, 2025 | AWARD | 19,500 | — | — | Form 4 |
| Cowan Chad | Chief Scientific Officer | Mar 11, 2025 | AWARD | 19,500 | $0.60 | $11.7K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Mar 11, 2025 | AWARD | 521,500 | — | — | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Mar 10, 2025 | SELL | 2,235 | $0.61 | $1.4K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Mar 11, 2025 | AWARD | 521,500 | $0.60 | $313.4K | Form 4 |
| Russotti Gregory | See Remarks | Mar 11, 2025 | AWARD | 120,000 | — | — | Form 4 |
| Russotti Gregory | See Remarks | Mar 10, 2025 | SELL | 2,360 | $0.61 | $1.5K | Form 4 |
| Russotti Gregory | See Remarks | Mar 11, 2025 | AWARD | 120,000 | $0.60 | $72.1K | Form 4 |
| Farid Adrienne | Chief Operations Officer | Mar 11, 2025 | AWARD | 120,000 | — | — | Form 4 |
| Farid Adrienne | Chief Operations Officer | Mar 10, 2025 | SELL | 2,359 | $0.61 | $1.5K | Form 4 |
| Farid Adrienne | Chief Operations Officer | Mar 11, 2025 | AWARD | 120,000 | $0.60 | $72.1K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Mar 11, 2025 | AWARD | 95,625 | — | — | Form 4 |
| Carr Douglas | SVP Finance & Operations | Mar 10, 2025 | SELL | 1,240 | $0.61 | $762.60 | Form 4 |
| Carr Douglas | SVP Finance & Operations | Mar 11, 2025 | AWARD | 95,625 | $0.60 | $57.5K | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Feb 18, 2025 | SELL | 34,712 | $0.78 | $27.2K | Form 4 |
| Farid Adrienne | Chief Operations Officer | Feb 3, 2025 | SELL | 1,054 | $0.78 | $822.12 | Form 4 |
| Carr Douglas | SVP Finance & Operations | Feb 3, 2025 | SELL | 351 | $0.78 | $273.78 | Form 4 |
| Pfeiffenberger Brent | director, officer: President and CEO | Dec 4, 2024 | TAX W/H | 243,447 | $1.44 | $350.6K | Form 4 |
| Farid Adrienne | Chief Operations Officer | Nov 4, 2024 | SELL | 1,033 | $1.23 | $1.3K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Nov 1, 2024 | TAX W/H | 16,611 | $1.26 | $20.9K | Form 4 |
| Carr Douglas | SVP Finance & Operations | Nov 4, 2024 | SELL | 283 | $1.23 | $347.24 | Form 4 |